润达医疗 (603108)

Shanghai Runda Medical Technology Co., Ltd.

ASH

Tags

AIGC ConceptAI HealthcareAI AgentsDeepSeekSSE 380 IndexArtificial Intelligence (AI)Venture Capital ConceptPharmaceuticals and HealthcarePharmaceutical CommerceContains Convertible BondsHelicobacter PyloriWholesalePlanned Reduction of HoldingsSmart HealthcareEnergy Conservation and Environmental ProtectionMargin Trading and Securities Lending

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 60367.58
  • Circulating A-Shares(W): 60367.58
  • Earnings Per Share(RMB): -0.2700
  • Net Assets Per Share(RMB): 6.8382
  • Operating Revenue(W RMB): 526845.96
  • Total Profit(W RMB): -6178.78
  • **Net Profit Attributable to Parent(W RMB) **: -16269.15
  • Net Profit Growth Rate(%): -422.64
  • Weighted Return on Equity(%): -3.8100
  • Operating Cash Flow Per Share(RMB): 0.7270
  • Undistributed Profit Per Share(RMB): 3.5697
  • Capital Reserve Per Share(RMB): 2.0672

2. Main Business

The main business covers:

  • Providing comprehensive services of in vitro diagnostic products and professional technical support to various medical laboratories

3. Company Basic Information

  • Company Name: Shanghai Runda Medical Technology Co., Ltd.
  • Listing Date: 2015-05-27
  • Industry: Pharmaceutical and Medical - Pharmaceutical Commerce
  • Address: Room 201, Building 1, No. 1018 Weichang Road, Jinshan District, Shanghai
  • Website: https://www.rundamedical.com/
  • Company Profile: Shanghai Runda Medical Technology Co., Ltd. was established through the overall transformation of Shanghai Runda Economic and Trade Co., Ltd. based on the audited net assets of RMB 136,593,449.75 as of July 31, 2010, converted at a ratio of 1:0.4832 into 66 million shares. On December 17, 2010, Runda Medical completed the industrial and commercial change registration at the Shanghai Administration for Industry and Commerce, with registration number 310228000244163, registered capital of 66 million yuan, paid-in capital of 66 million yuan, and legal representative Liu Hui. After two capital increases since the establishment of the joint stock company, as of the signing date of this prospectus, Runda Medical's registered capital and paid-in capital were both 70.526316 million yuan.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Hangzhou Gongshu District State-owned Investment Group Co., Ltd. Corporate Entity 11600.00 19.22
2 Jiujiang Haocheng Investment Management Center (Limited Partnership) Corporate Entity 818.53 1.36
3 Southern China Securities 1000 ETF Fund 441.19 0.73
4 Hong Kong Securities Clearing Company Ltd. Northbound Capital 415.16 0.69
5 Great Wall Consumption Value-Added Mixed Securities Investment Fund Class A Fund 300.00 0.50
6 Yuansin Yongfeng Pharmaceutical Health Mixed Securities Investment Fund Class A Fund 236.00 0.39
7 Yuansin Yongfeng Juyou Stock Securities Investment Fund Class A Fund 168.50 0.28
8 Yuansin Yongfeng Xingyuan Flexible Allocation Mixed Securities Investment Fund Class A Fund 79.16 0.13
9 Wanjia Health Industry Mixed Securities Investment Fund Class A Fund 34.92 0.06
10 Huaxi Research Selected Mixed Initiation Securities Investment Fund Class A Fund 17.28 0.03

5. Concept Sectors

  • Convertible Bonds
  • Venture Capital Concept
  • Energy Saving and Environmental Protection
  • Intelligent Healthcare
  • Artificial Intelligence
  • Helicobacter Pylori
  • AIGC Concept
  • AI Agent
  • DeepSeek
  • AI Healthcare

Remarks

  • Data update date: 2025-11-03
  • Data source: Public market information